Elaine Sun

Elaine Sun

Director/Board Member at DYNAVAX TECHNOLOGIES CORPORATION

Net worth: 558 057 $ as of 2024-02-28

53 year
Health Technology
Finance
Consumer Services

Profile

Elaine D. Sun occupies the position of Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. Ms. Sun is also on the board of Cirius Therapeutics, Inc. In the past Ms. Sun was Chief Financial & Strategy Officer at Vaxcyte, Inc., Managing Director at Merrill Lynch & Co., Inc. and Managing Director at Evercore Capital Partners. She received an undergraduate degree from Wellesley College and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2023-03-05 14,018 ( 0.01% ) 558 057 $ 2024-02-28
2023-03-14 0 ( -.--% ) - $ 2024-02-28

Elaine Sun active positions

CompaniesPositionStart
DYNAVAX TECHNOLOGIES CORPORATION Director/Board Member 2021-12-09
Director of Finance/CFO 2022-03-22
Director/Board Member 2023-01-04
All active positions of Elaine Sun

Former positions of Elaine Sun

CompaniesPositionEnd
HALOZYME THERAPEUTICS, INC. Director of Finance/CFO 2022-02-01
VAXCYTE, INC. Director of Finance/CFO 2019-11-30
Director/Board Member -
Corporate Officer/Principal -
Private Equity Investor -
See the detail of Elaine Sun's experience

Training of Elaine Sun

Wellesley College Undergraduate Degree
Harvard Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Elaine Sun's experience

Connections

54

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies3
DYNAVAX TECHNOLOGIES CORPORATION

Health Technology

HALOZYME THERAPEUTICS, INC.

Health Technology

VAXCYTE, INC.

Health Technology

Private companies5

Finance

Finance

Health Technology

Technology Services

Commercial Services

See company connections
  1. Stock
  2. Insiders
  3. Elaine Sun